Early Antiretroviral Therapy May Preserve Vaccine Responses in Human Immunodeficiency Virus-Infected Patients by Preventing Damage to Long-Lived Plasma Cells
- 23 December 2019
- journal article
- editorial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 222 (2), 176-179
- https://doi.org/10.1093/infdis/jiz679
Abstract
No abstract availableFunding Information
- Swedish Medical Research Council (2017-02001, 2016-01165)
- Swedish Childhood Cancer Fund (2014-0112)
This publication has 23 references indexed in Scilit:
- Mass cytometry identifies distinct CD4+ T cell clusters distinguishing HIV-1–infected patients according to antiretroviral therapy initiationJCI Insight, 2019
- Early Antiretroviral Therapy Preserves Functional Follicular Helper T and HIV-Specific B Cells in the Gut Mucosa of HIV-1–Infected IndividualsThe Journal of Immunology, 2018
- Initiation of Antiretroviral Therapy in Early Asymptomatic HIV InfectionThe New England Journal of Medicine, 2015
- B-cell exhaustion in HIV infectionCurrent Opinion in HIV and AIDS, 2014
- CD8+ T Cells Are Activated in an Antigen-Independent Manner in HIV-Infected IndividualsThe Journal of Immunology, 2014
- Impairment of B-cell functions during HIV-1 infectionAIDS, 2013
- The establishment of the plasma cell survival niche in the bone marrowImmunological Reviews, 2012
- Smallpox as a Biological WeaponJAMA, 1999
- Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humansNature Medicine, 1999
- Outbreak of Smallpox in the Lower Rio Grande Valley of Texas in 1949American Journal of Public Health and the Nations Health, 1953